The overexpression of oncogene products also contributes to paclitaxel resistance, among which the transcription factor signal transducer and activator of transcription 3 (STAT3) is frequently overexpressed and activated in paclitaxel-resistant breast cancer and is associated with tubulin [6]. This evidence concerns the gene STAT3 and breast carcinoma.